Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com.
Looking for a particular Terns Pharmaceuticals employee's phone or email?
Terns Pharmaceuticals Questions
The Terns Pharmaceuticals annual revenue was $13.9 million in 2026.
Andrew Gengos is the CFO and Head of Corporate Development of Terns Pharmaceuticals.
55 people are employed at Terns Pharmaceuticals.
Terns Pharmaceuticals is based in Foster City, California.
The NAICS codes for Terns Pharmaceuticals are [32541, 32, 541, 3254, 325, 54].
The SIC codes for Terns Pharmaceuticals are [28, 283].
Top Terns Pharmaceuticals Employees
-
25+
-
Emil Kuriakose
Chief Medical Officer at Terns Pharmaceuticals
Houston, TX, US35+ -
Melita Jung
Chief Business Officer at Terns Pharmaceuticals
San Francisco, CA, US55+ -
Caryn McDowell
Chief Legal Officer and Corporate Secretary at Terns Pharmaceuticals
California, United States34 -
Christine Liu
VP, Deputy General Counsel at Terns Pharmaceuticals
Burlingame, CA, US23 -
Debra Sieminski
SVP, Medical Affairs at Terns Pharmaceuticals
New York, NY, US24 -
25+
Related Companies
